Houlihan Lokey, Inc. $HLI Shares Sold by Rhumbline Advisers

Rhumbline Advisers lessened its holdings in Houlihan Lokey, Inc. (NYSE:HLI) by 5.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 155,459 shares of the financial services provider’s stock after selling 8,236 shares during the quarter. Rhumbline Advisers owned 0.22% of Houlihan Lokey worth $31,919,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Mayflower Financial Advisors LLC purchased a new position in shares of Houlihan Lokey during the third quarter worth $230,335,000. Baker Ellis Asset Management LLC acquired a new stake in Houlihan Lokey during the 3rd quarter worth about $589,000. Thrivent Financial for Lutherans raised its stake in shares of Houlihan Lokey by 75.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 713,494 shares of the financial services provider’s stock valued at $146,495,000 after buying an additional 307,214 shares during the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of Houlihan Lokey by 63.2% in the 2nd quarter. Geneos Wealth Management Inc. now owns 33,430 shares of the financial services provider’s stock valued at $6,016,000 after buying an additional 12,944 shares during the period. Finally, QRG Capital Management Inc. lifted its holdings in shares of Houlihan Lokey by 112.7% in the 3rd quarter. QRG Capital Management Inc. now owns 11,607 shares of the financial services provider’s stock valued at $2,383,000 after buying an additional 6,150 shares during the period. Hedge funds and other institutional investors own 78.07% of the company’s stock.

Insider Buying and Selling at Houlihan Lokey

In related news, General Counsel Christopher M. Crain sold 500 shares of the company’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $174.17, for a total transaction of $87,085.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Robert A. Schriesheim sold 5,000 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $170.86, for a total transaction of $854,300.00. Following the completion of the sale, the director owned 27,982 shares of the company’s stock, valued at approximately $4,781,004.52. The trade was a 15.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 22.83% of the company’s stock.

Analysts Set New Price Targets

HLI has been the topic of a number of recent analyst reports. Morgan Stanley lowered their price target on shares of Houlihan Lokey from $216.00 to $215.00 and set an “overweight” rating on the stock in a report on Tuesday, January 6th. Weiss Ratings lowered shares of Houlihan Lokey from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. BMO Capital Markets raised their target price on Houlihan Lokey from $209.00 to $211.00 and gave the company an “outperform” rating in a research report on Thursday, January 29th. Keefe, Bruyette & Woods reduced their price target on Houlihan Lokey from $218.00 to $214.00 and set an “outperform” rating for the company in a report on Thursday, January 29th. Finally, UBS Group reiterated a “neutral” rating and set a $196.00 price target on shares of Houlihan Lokey in a research report on Friday, January 30th. Four equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $209.17.

Houlihan Lokey Stock Up 0.0%

HLI opened at $165.85 on Monday. The company has a market cap of $11.57 billion, a PE ratio of 25.48 and a beta of 0.94. Houlihan Lokey, Inc. has a twelve month low of $137.99 and a twelve month high of $211.78. The company has a 50-day moving average price of $178.01 and a 200 day moving average price of $186.88.

Houlihan Lokey (NYSE:HLI) last posted its quarterly earnings data on Wednesday, January 28th. The financial services provider reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $717.07 million during the quarter, compared to analyst estimates of $696.72 million. Houlihan Lokey had a return on equity of 24.46% and a net margin of 16.91%.Houlihan Lokey’s quarterly revenue was up 13.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.64 EPS. As a group, sell-side analysts expect that Houlihan Lokey, Inc. will post 5.98 earnings per share for the current year.

Houlihan Lokey Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Sunday, March 15th. Shareholders of record on Monday, March 2nd will be issued a $0.60 dividend. The ex-dividend date is Monday, March 2nd. This represents a $2.40 dividend on an annualized basis and a yield of 1.4%. Houlihan Lokey’s dividend payout ratio (DPR) is presently 36.87%.

About Houlihan Lokey

Houlihan Lokey, Inc is a global investment bank and financial services firm founded in 1972 and headquartered in Los Angeles, California. The company specializes in advisory services across a broad range of transaction types and financial matters. Since its founding, Houlihan Lokey has grown to serve corporations, financial sponsors, and government entities worldwide, providing expertise in complex and high-stakes engagements.

The firm’s core service offerings include mergers and acquisitions advisory, capital markets advisory, financial restructuring and distressed M&A, and valuation and fairness opinions.